US 11548943
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11548943 (Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof) held by CytomX Therapeutics, Inc. expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CytomX Therapeutics, Inc.
- Grant date
- Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K38/05, A61K47/6849